Oyster Point Pharma, Inc.
DelistedCIK 1720725fmd_0HCTF4T6AGS2VKF5R7E7DR966HManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2018 to Sep 30, 2022, 19 periods
Latest annual · FY2021
Millions- Total revenues
- 25
- Gross profit
- 23
- Operating income
- (97)
- Net income
- (101)
- Free cash flow
- (91)
Latest quarter · Q3 FY2022
Millions- Total revenues
- 6
- Gross profit
- 4
- Operating income
- (34)
- Net income
- (37)
- Free cash flow
- (36)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- n/m
Oyster Point Pharma, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $24.5 million | $0 | 10-K 2022-02-24 · proof | |
| Gross profit | $23 million | $0 | 10-K 2022-02-24 · proof | |
| Operating income | -$96.7 million | -$71 million | 10-K 2022-02-24 · proof | |
| Net income | -$100.7 million | -$70.5 million | 10-K 2022-02-24 · proof | |
| Cash from operating activities | -$89.4 million | -$58.4 million | 10-K 2022-02-24 · proof | |
| Free cash flow | -$90.9 million | -$59.1 million | 10-K 2022-02-24 · proof | |
| Total assets | $222.6 million | $197.9 million | +12.5% | 10-K 2022-02-24 · proof |
| Total liabilities | $123.1 million | $11.3 million | +993.9% | 10-K 2022-02-24 · proof |
| Cash and cash equivalents | $193.4 million | $192.6 million | +0.4% | 10-K 2022-02-24 · proof |
- What was Oyster Point Pharma, Inc.'s revenue in fiscal 2021?
- Oyster Point Pharma, Inc. reported revenue of $24.5 million for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What was Oyster Point Pharma, Inc.'s gross profit in fiscal 2021?
- Oyster Point Pharma, Inc. reported gross profit of $23 million for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What was Oyster Point Pharma, Inc.'s operating income in fiscal 2021?
- Oyster Point Pharma, Inc. reported operating income of -$96.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$71 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What was Oyster Point Pharma, Inc.'s net income in fiscal 2021?
- Oyster Point Pharma, Inc. reported net income of -$100.7 million for fiscal 2021 (the year ended Dec 31, 2021), against -$70.5 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What was Oyster Point Pharma, Inc.'s cash from operating activities in fiscal 2021?
- Oyster Point Pharma, Inc. reported cash from operating activities of -$89.4 million for fiscal 2021 (the year ended Dec 31, 2021), against -$58.4 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What was Oyster Point Pharma, Inc.'s free cash flow in fiscal 2021?
- Oyster Point Pharma, Inc. reported free cash flow of -$90.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$59.1 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What are Oyster Point Pharma, Inc.'s total assets?
- As of Dec 31, 2021, Oyster Point Pharma, Inc. reported total assets of $222.6 million, against $197.9 million a year earlier (+12.5%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What are Oyster Point Pharma, Inc.'s total liabilities?
- As of Dec 31, 2021, Oyster Point Pharma, Inc. reported total liabilities of $123.1 million, against $11.3 million a year earlier (+993.9%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
- What are Oyster Point Pharma, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, Oyster Point Pharma, Inc. reported cash and cash equivalents of $193.4 million, against $192.6 million a year earlier (+0.4%). Source: the 10-K filed with the SEC on Feb 24, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1720725&period_type=annual&limit=5"Information only, not investment advice.